Mangalam Drugs and Organics Ltd
NSE:MANGALAM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Entero Healthcare Solutions Ltd
NSE:ENTERO
|
IN |
|
Liberty Media Corp
NASDAQ:FWONA
|
US |
|
G M Breweries Ltd
NSE:GMBREW
|
IN |
|
Soluna Holdings Inc
NASDAQ:SLNH
|
US |
|
A
|
Awardit AB publ
STO:AWRD
|
SE |
|
Methanor SCA
PAR:ALMET
|
FR |
|
Kerry Logistics Network Ltd
HKEX:636
|
HK |
|
Express Transindo Utama Tbk PT
IDX:TAXI
|
ID |
|
China Merchants Property Operation & Service Co Ltd
SZSE:001914
|
CN |
|
Stockwik Forvaltning AB
STO:STWK
|
SE |
|
P
|
Peugeot Invest SA
LSE:0HV8
|
FR |
|
Spencer's Retail Ltd
NSE:SPENCERS
|
IN |
|
Beijing Strong Biotechnologies Inc
SZSE:300406
|
CN |
|
Celyad Oncology SA
XBRU:CYAD
|
BE |
|
B
|
Beijing Succeeder Technology Inc
SSE:688338
|
CN |
|
BAIC Motor Corp Ltd
HKEX:1958
|
CN |
|
G-Next Inc
TSE:4179
|
JP |
Mangalam Drugs and Organics Ltd
Research & Development
Mangalam Drugs and Organics Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mangalam Drugs and Organics Ltd
NSE:MANGALAM
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Mangalam Drugs and Organics Ltd
Glance View
Mangalam Drugs & Organics Ltd. engages in the manufacture of drugs, medicines and allied products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-05-26. The firm handles marketing in both domestic and export markets. The firm is also engaged in the Fight Malaria program for the supply of anti-malarial APIs worldwide. Its API products include Acyclovir, Amodiaquine HCI, Artemether, Artesunate, Atazanavir Sulfate, Atorvastatin Calcium, Bisoprolol Fumarate and Furosemide. Its intermediates products include 4,6-Dichloro-5-Methoxy Pyrimidine, 2-Dibutylamino-1-Ethanol (DBA), 4,7- Dichloroquinoline, Ortho Phenoxy Methane Sulfonanilide, Tenofovir Alafenamide Base and Tenofovir Disoproxil Base. The company also offers specialty chemicals, such a L (+)-Menthol, 2,3 Dihydrophthalazine-1,4-dione, 4-Cynoethyl-2- Methyl Phenol. The firm offers its products to Italy, Russia, China, Turkey, Nigeria, Uganda, Kenya and Pakistan. The company has two multi-product manufacturing facilities located at Vapi, district Valsad, Gujarat.
